Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-15-000037
Filing Date
2015-03-09
Accepted
2015-03-09 19:26:30
Documents
1
Period of Report
2015-03-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 8496
  Complete submission text file 0000874015-15-000037.txt   9792
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address
WENDER JOSEPH H (Reporting) CIK: 0001073384 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 15686716